110 related articles for article (PubMed ID: 29040187)
1. Palliative Radiation Therapy for Recurrent Ovarian Cancer: Efficacy and Predictors of Clinical Response.
Jiang G; Balboni T; Taylor A; Liu J; Lee LJ
Int J Gynecol Cancer; 2018 Jan; 28(1):43-50. PubMed ID: 29040187
[TBL] [Abstract][Full Text] [Related]
2. Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial.
Chang JS; Kim SW; Kim YJ; Kim JY; Park SY; Kim JH; Jang TK; Kim YB
Gynecol Oncol; 2018 Oct; 151(1):39-45. PubMed ID: 30146110
[TBL] [Abstract][Full Text] [Related]
3. Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure.
Corn BW; Lanciano RM; Boente M; Hunter WM; Ladazack J; Ozols RF
Cancer; 1994 Dec; 74(11):2979-83. PubMed ID: 7525039
[TBL] [Abstract][Full Text] [Related]
4. Whole abdominopelvic radiotherapy using intensity-modulated arc therapy in the palliative treatment of chemotherapy-resistant ovarian cancer with bulky peritoneal disease: a single-institution experience.
De Meerleer G; Vandecasteele K; Ost P; Delrue L; Denys H; Makar A; Speleers B; Van Belle S; Van den Broecke R; Fonteyne V; De Neve W
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):775-81. PubMed ID: 20421155
[TBL] [Abstract][Full Text] [Related]
5. Effective palliative radiotherapy for symptomatic recurrent or residual ovarian cancer.
E C; Quon M; Gallant V; Samant R
Gynecol Oncol; 2006 Aug; 102(2):204-9. PubMed ID: 16427685
[TBL] [Abstract][Full Text] [Related]
6. Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma.
Tinger A; Waldron T; Peluso N; Katin MJ; Dosoretz DE; Blitzer PH; Rubenstein JH; Garton GR; Nakfoor BA; Patrice SJ; Chuang L; Orr JW
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1256-63. PubMed ID: 11728685
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy for isolated recurrent epithelial ovarian cancer: A single institutional experience.
Komura N; Mabuchi S; Isohashi F; Yokoi E; Shimura K; Matsumoto Y; Kodama M; Tomimatsu T; Ogawa K; Kimura T
J Obstet Gynaecol Res; 2019 Jun; 45(6):1173-1182. PubMed ID: 30843318
[TBL] [Abstract][Full Text] [Related]
8. Involved-field radiation therapy for locoregionally recurrent ovarian cancer.
Brown AP; Jhingran A; Klopp AH; Schmeler KM; Ramirez PT; Eifel PJ
Gynecol Oncol; 2013 Aug; 130(2):300-5. PubMed ID: 23648467
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for chemotherapy-resistant recurrent epithelial ovarian cancer.
Machida S; Takei Y; Yoshida C; Takahashi Y; Koyanagi T; Sato N; Taneichi A; Saga Y; Fujiwara H; Suzuki M
Oncology; 2014; 86(4):232-8. PubMed ID: 24853194
[TBL] [Abstract][Full Text] [Related]
10. Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy.
Yahara K; Ohguri T; Imada H; Yamaguchi S; Kawagoe T; Matsuura Y; Hachisuga T; Korogi Y
J Radiat Res; 2013 Mar; 54(2):322-9. PubMed ID: 23179378
[TBL] [Abstract][Full Text] [Related]
11. Computed tomography-guided 125I seed interstitial implantation in the treatment of recurrent ovarian cancer.
Wang Y; Zhang W; Liu P; Guo Z; Ni H
Int J Gynecol Cancer; 2014 Oct; 24(8):1414-9. PubMed ID: 25248113
[TBL] [Abstract][Full Text] [Related]
12. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
[TBL] [Abstract][Full Text] [Related]
13. Role of radiation therapy.
Eifel PJ
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():118-125. PubMed ID: 27986398
[TBL] [Abstract][Full Text] [Related]
14. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
[TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence and role of pelvic radiotherapy in ovarian clear cell adenocarcinoma.
Macrie BD; Strauss JB; Helenowski IB; Rademaker A; Schink JC; Lurain JR; Small W
Int J Gynecol Cancer; 2014 Nov; 24(9):1597-602. PubMed ID: 25275661
[TBL] [Abstract][Full Text] [Related]
16. Preoperative predictors that impact the survival and outcome of patients undergoing secondary cytoreduction for ovarian cancer.
Katsnelson M; Hwang WT; Tahirovic E; Rubin SC; Tanyi JL
J Obstet Gynaecol; 2018 Apr; 38(3):395-401. PubMed ID: 29385863
[TBL] [Abstract][Full Text] [Related]
17. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcome of patients with recurrent epithelial ovarian carcinoma: is it the same for each histological type?
Kajiyama H; Shibata K; Mizuno M; Umezu T; Suzuki S; Yamamoto E; Fujiwara S; Kawai M; Nagasaka T; Kikkawa F
Int J Gynecol Cancer; 2012 Mar; 22(3):394-9. PubMed ID: 22391762
[TBL] [Abstract][Full Text] [Related]
19. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.
Salani R; Santillan A; Zahurak ML; Giuntoli RL; Gardner GJ; Armstrong DK; Bristow RE
Cancer; 2007 Feb; 109(4):685-91. PubMed ID: 17219441
[TBL] [Abstract][Full Text] [Related]
20. Long-term Benefit of Tumor Volume-Directed Involved Field Radiation Therapy in the Management of Recurrent Ovarian Cancer.
Albuquerque K; Patel M; Liotta M; Harkenrider M; Guo R; Small W; Ronald P
Int J Gynecol Cancer; 2016 May; 26(4):655-60. PubMed ID: 26825832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
